Literature DB >> 11834719

Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities.

Roberto Motterlini1, James E Clark, Roberta Foresti, Padmini Sarathchandra, Brian E Mann, Colin J Green.   

Abstract

Carbon monoxide (CO) is generated in living organisms during the degradation of heme by the enzyme heme oxygenase, which exists in constitutive (HO-2 and HO-3) and inducible (HO-1) isoforms. Carbon monoxide gas is known to dilate blood vessels in a manner similar to nitric oxide and has been recently shown to possess antiinflammatory and antiapoptotic properties. We report that a series of transition metal carbonyls, termed here carbon monoxide-releasing molecules (CO-RMs), liberate CO to elicit direct biological activities. Specifically, spectrophotometric and NMR analysis revealed that dimanganese decacarbonyl and tricarbonyldichlororuthenium (II) dimer release CO in a concentration-dependent manner. Moreover, CO-RMs caused sustained vasodilation in precontracted rat aortic rings, attenuated coronary vasoconstriction in hearts ex vivo, and significantly reduced acute hypertension in vivo. These vascular effects were mimicked by induction of HO-1 after treatment of animals with hemin, which increases endogenously generated CO. Thus, we have identified a novel class of compounds that are useful as prototypes for studying the bioactivity of CO. In the long term, transition metal carbonyls could be utilized for the therapeutic delivery of CO to alleviate vascular- and immuno-related dysfunctions. The full text of this article is available at http://www.circresaha.org.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834719     DOI: 10.1161/hh0202.104530

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  196 in total

1.  Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.

Authors:  Wei-chang Shen; Xu Wang; Wei-ting Qin; Xue-feng Qiu; Bing-wei Sun
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

Review 2.  Toward Carbon Monoxide-Based Therapeutics: Critical Drug Delivery and Developability Issues.

Authors:  Xingyue Ji; Krishna Damera; Yueqin Zheng; Bingchen Yu; Leo E Otterbein; Binghe Wang
Journal:  J Pharm Sci       Date:  2016-01-06       Impact factor: 3.534

3.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 4.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

5.  Enhanced expression of heme oxygenase-1 and carbon monoxide excitatory effects in oxytocin and vasopressin neurones during water deprivation.

Authors:  W L Reis; V C Biancardi; S Son; J Antunes-Rodrigues; J E Stern
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

6.  Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction.

Authors:  Hayato Matsumoto; Kazunobu Ishikawa; Hiroyuki Itabe; Yukio Maruyama
Journal:  Mol Cell Biochem       Date:  2006-04-20       Impact factor: 3.396

Review 7.  Carbon monoxide--physiology, detection and controlled release.

Authors:  Stefan H Heinemann; Toshinori Hoshi; Matthias Westerhausen; Alexander Schiller
Journal:  Chem Commun (Camb)       Date:  2014-04-11       Impact factor: 6.222

8.  Pharmacological activation of heme oxygenase (HO)-1/carbon monoxide pathway prevents the development of peripheral neuropathic pain in Wistar rats.

Authors:  Krishna Reddy V Bijjem; Satyanarayana S V Padi; Pyare lal Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

9.  Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics.

Authors:  João D Seixas; Abhik Mukhopadhyay; Teresa Santos-Silva; Leo E Otterbein; David J Gallo; Sandra S Rodrigues; Bruno H Guerreiro; Ana M L Gonçalves; Nuno Penacho; Ana R Marques; Ana C Coelho; Patrícia M Reis; Maria J Romão; Carlos C Romão
Journal:  Dalton Trans       Date:  2013-05-07       Impact factor: 4.390

10.  CO liberated from CORM-2 modulates the inflammatory response in the liver of thermally injured mice.

Authors:  Bing-Wei Sun; Yan Sun; Zhi-Wei Sun; Xi Chen
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.